| Item Type | Name |
|
Concept
|
Mutation
|
|
Concept
|
Mutation, Missense
|
|
Concept
|
Mutation Rate
|
|
Academic Article
|
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
|
|
Academic Article
|
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
|
|
Academic Article
|
BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
|
|
Academic Article
|
STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.
|
|
Academic Article
|
A comparison of two methods for screening CEBPA mutations in patients with acute myeloid leukemia.
|
|
Academic Article
|
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
|
|
Academic Article
|
Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?
|
|
Academic Article
|
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with =30% blasts in older adults: a Bone Marrow Pathology Group study.
|
|
Academic Article
|
The diagnostic and clinical impact of genetics and epigenetics in acute myeloid leukemia.
|
|
Academic Article
|
Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis.
|
|
Academic Article
|
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
|
|
Academic Article
|
STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression.
|
|
Academic Article
|
A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.
|
|
Academic Article
|
Histologic and molecular analyses of colonic perineurial-like proliferations in serrated polyps: perineurial-like stromal proliferations are seen in sessile serrated adenomas.
|
|
Academic Article
|
Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance.
|
|
Academic Article
|
Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation.
|
|
Academic Article
|
Reclassifying myelodysplastic syndromes: what's where in the new WHO and why.
|
|
Academic Article
|
Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
|
|
Academic Article
|
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.
|
|
Academic Article
|
A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
|
|
Academic Article
|
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.
|
|
Academic Article
|
A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
|
|
Academic Article
|
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
|
|
Academic Article
|
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.
|
|
Academic Article
|
Frequency of MAP2K1, TP53, and U2AF1 Mutations in BRAF-mutated Langerhans Cell Histiocytosis: Further Characterizing the Genomic Landscape of LCH.
|
|
Academic Article
|
High-throughput Sequencing of Subcutaneous Panniculitis-like T-Cell Lymphoma Reveals Candidate Pathogenic Mutations.
|
|
Academic Article
|
How I investigate chronic myelomonocytic leukemia.
|
|
Academic Article
|
Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1.
|
|
Academic Article
|
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.
|
|
Academic Article
|
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.
|
|
Academic Article
|
Erythroleukemia: an Update.
|
|
Academic Article
|
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases.
|
|
Academic Article
|
NPM1 exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoring.
|
|
Academic Article
|
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.
|
|
Academic Article
|
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype.
|
|
Academic Article
|
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
|
|
Academic Article
|
Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation.
|
|
Academic Article
|
Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study.
|
|
Academic Article
|
Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group.
|
|
Academic Article
|
Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach.
|
|
Academic Article
|
Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalities.
|
|
Academic Article
|
STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.
|
|
Academic Article
|
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q).
|
|
Academic Article
|
Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis.
|
|
Academic Article
|
Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.
|